Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Egilsson

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
International Journal of Cancer|December 20, 1995
Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regionsG Eiriksdottir, A Sigurdsson, J G Jonasson, et al.
Journal of Medical Genetics|July 13, 2002
The effect of a single BRCA2 mutation on cancer in IcelandH Tulinius, G H Olafsdottir, H Sigvaldason, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosisG Eiriksdottir, G Johannesdottir, S Ingvarsson, et al.
Cancer Research|August 15, 1996
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patientsG Johannesdottir, J Gudmundsson, J T Bergthorsson, et al.
Cancer Research|October 10, 1998
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutationS Ingvarsson, E K Geirsdottir, G Johannesdottir, et al.
European Journal of Human Genetics : EJHG|January 10, 2002
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer familiesR B Barkardottir, L Sarantaus, A Arason, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2000
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locusT Kainu, S H Juo, R Desper, et al.
Journal of the National Cancer Institute|August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsS R Lakhani, J Jacquemier, J P Sloane, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
International Journal of Cancer|December 20, 1995
Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regionsG Eiriksdottir, A Sigurdsson, J G Jonasson, et al.
Journal of Medical Genetics|July 13, 2002
The effect of a single BRCA2 mutation on cancer in IcelandH Tulinius, G H Olafsdottir, H Sigvaldason, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosisG Eiriksdottir, G Johannesdottir, S Ingvarsson, et al.
Cancer Research|August 15, 1996
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patientsG Johannesdottir, J Gudmundsson, J T Bergthorsson, et al.
Cancer Research|October 10, 1998
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutationS Ingvarsson, E K Geirsdottir, G Johannesdottir, et al.
European Journal of Human Genetics : EJHG|January 10, 2002
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer familiesR B Barkardottir, L Sarantaus, A Arason, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2000
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locusT Kainu, S H Juo, R Desper, et al.
Journal of the National Cancer Institute|August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsS R Lakhani, J Jacquemier, J P Sloane, et al.
Pageof 5